MedTrace Logo

Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT

NCT04996147 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2021-08-09

No results posted yet for this study

Summary

Head and Neck Squamous Cell Carcinoma (HNSCC) is the 6th most common cancer. Most cases are diagnosed in locally advanced stages, with treatment involving multimodal approach with combinations of radiotherapy, surgery and chemotherapy. The aggressive nature of HNSCCs and treatment modalities are associated with important acute and late toxicities that often promote temporary or definitive treatment interruption and may compromised the capability to tolerate subsequent treatments. Thus, the aim of this study is to analyze the acute and long-term impact of cancer treatment on quality of life, physical and cognitive function of HNSCC patients diagnosed with a locally advanced disease.

Conditions

  • Head and Neck Neoplasms

Sponsors & Collaborators

  • Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

    collaborator OTHER_GOV

  • University Institute of Maia

    collaborator OTHER

  • Associacao de Investigacao de Cuidados de Suporte em Oncologia

    lead OTHER

Principal Investigators

  • Inês Leão, MD · Centro Hospitalar Vila Nova de Gaia / Espinho

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-03-03
Completion
2020-03-03

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04996147 on ClinicalTrials.gov